In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Research Laboratories

Division of Merck & Co. Inc.
www.merck.com/mrl/

Latest From Merck Research Laboratories

Merck And The 'Strange Business' Of Antibiotics

Antibacterials have been part of Merck's mission for decades, despite the market challenges, and it's expecting two new approvals this year. Infectious disease VP Joan Butterton talks about tackling those challenges and incentives that may help the industry address antimicrobial resistance.

Infectious Diseases Research and Development Strategies

US FDA Plans To Standardize Review Of Blood Pressure Effects Of New Drugs

Approach is modeled after the interdisciplinary review team established more than a decade ago to review data on QT interval effects, FDA says; at a recent Duke meeting on assessing off-target pressor effects, discussion focused on lessons learned in the QT space that could be applied to studying blood pressure effects.

Drug Safety Research and Development Strategies

Peter Stein Takes Short Path To Director Of US FDA Drug Office

An industry veteran, Stein has been with agency for only two years; Bob Temple becomes powerful OND "consultant."
FDA Drug Review

US FDA Office Of New Drugs Likely To Be Headed By Deputy Director Stein

Peter Stein is a familiar face within OND and has been working alongside CDER Director Janet Woodcock on the proposed “modernization” of OND. As a previous recruit from outside FDA, Stein has had time to make the key connections and adjustments to working inside government.
FDA Leadership
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merck & Co. Inc.
  • Senior Management
  • Roger M Perlmutter, MD, PhD, EVP, Pres.
  • Contact Info
  • Merck Research Laboratories
    Phone: (908) 594-4000
    1 Merck Drive
    P. O. Box 100
    P.O. Box 2000 Whitehouse Station, NJ 07065-0900
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register